InSysBio to take part in ACoP12

6 1. 06 Jul 2020 17:37 InSysBio to announce the launch of its new tool Heta compiler Heta compiler has been published on GitHub as an OpenSource (Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.

27 1. 27 Jul 2020 11:45 InSysBio to evolve its Open Source QSP model of COVID-19 InSysBio has presented a new portion of results in the framework of development of COVID-19 QSP model. 2. 27 Jul 2020 16:42 InSysBio to present its posters at AAIC 2020 Virtual Event InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer's Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames

events

Conference

November 10, 2021

October 27, 2021

InSysBio announces its participation in Twelfth American Conference on Pharmacometrics (ACoP12) which is to be held in virtual format this year from November 8-12, 2021. The theme of ACoP12 is “Charting the Course for Our Future”. InSysBio team is going to present the update at its Virtual Booth and 12 posters in frames of the Conference, namely:

Tuesday, November 9:

Poster Session IA (8:00 - 8:45am AND 12:00 - 12:45pm EST)

PIA-010 "Heta language: Modularity and Reusability in QSP modeling platforms" by Evgeny Metelkin
PIA-014 "Comparison Of Different Approaches To Generate Virtual Patient Populations Of Different Sizes For QSP Model Of Erythropoiesis" by Galina Kolesova
PIA-023 "The QSP model of amyloid beta and tau oligomers influence on synaptic plasticity" by Stepan Lerner

Poster Session IB (8:45 - 9:30am AND 12:45 - 1:30pm EST)

PIB-013 "Quantitative systems pharmacology model for neurofilament L dynamics in Alzheimer's disease pathology" by Polina Pchelintseva, Tatiana Karelina
PIB-018 "PBPK/RO modeling of anti-PDL1 antibodies" by Antonina Nikitich, Oleg Demin Jr

Wednesday, November 10:

Poster Session IIA (8:00 - 8:45am AND 12:00 - 12:45pm EST)

PIIA-018 "Development of QSP model of COVID-19 based on Immune Response Template" by Veronika Musatova, Oleg Demin

Poster Session IIB (8:45 - 9:30am AND 12:45 - 1:30pm EST)

PIIB-006 "PBPK modeling of T cell distribution in cancer patients" by Dmitry Shchelokov¹, Oleg Demin Jr¹, Sara Brett² , Stefan Zajic³, Lourdes Cucurull-Sanchez²

Affiliation: ¹ InSysBio, Moscow, Russia; ² GlaxoSmithKline, Stevenage, Hertfordshire, UK; ³GlaxoSmithKline, Upper Providence, PA, USA

PIIB-031 "Investigation of inflammation during Alzheimer's disease by quantitative systems pharmacology model" by Tatiana Karelina

Thursday, November 11:

Poster Session IIIA (8:00 - 8:45am AND 12:00 - 12:30pm EST)

PIIIA-012 "Application of CYTOCON DB to compare cell/cytokine profile of patients with melanoma, NSCLC, and healthy subjects" by Vladislav Leonov
PIIIA-019 "A Quantitative Systems Pharmacology Model of adverse effects of PI3K? inhibitors on intestine inflammation" by Sergey Smirnov¹, Oleg Demin¹, Erqian Yu², Xiaomin Song², Sri Sahasranaman², Yan Ren²

Affiliation: ¹ InSysBio, Moscow, Russia; ² BeiGene, Beijing, China

Poster Session IIIB (8:45 - 9:30am AND 12:30 - 1:00pm EST)

PIIIB-013 "Semi-mechanistic PK/PD modeling of anti-CD47 therapeutic agent" by Elena Vasileva, Oleg Demin Jr
PIIIB-022 "HetaSimulator is an Open Source Simulation and Parameter Estimation Software for QSP Modeling" by Ivan Borisov, Evgeny Metelkin

Visit our Virtual Booth and follow our presenters!

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

←	July 2020	→
Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6 1. 06 Jul 2020 17:37 InSysBio to announce the launch of its new tool Heta compiler Heta compiler has been published on GitHub as an OpenSource (Moscow-06.07.2020) InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents Heta compiler which is a tool for the development of Quantitative Systems Pharmacology and Systems Biology platforms. Particularly, it allows combining modules written in different formats like: Heta language code, Excel sheets, JSON, YAML formatted structures, SBML and transforming them into the dynamic models of different formats.	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27 1. 27 Jul 2020 11:45 InSysBio to evolve its Open Source QSP model of COVID-19 InSysBio has presented a new portion of results in the framework of development of COVID-19 QSP model. 2. 27 Jul 2020 16:42 InSysBio to present its posters at AAIC 2020 Virtual Event InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer's Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames	28	29	30	31

Upcoming Events